Stay updated on KN035 Anti-PD-L1 Clinical Trial

Sign up to get notified when there's something new on the KN035 Anti-PD-L1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KN035 Anti-PD-L1 Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical trial record for the KN035 Phase 1 study is displayed, including study design, participant criteria, locations, and outcome measures. The record also includes publications, investigator details, and registration history.
    Difference
    41%
    Check dated 2026-11-07T11:32:24.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the study page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T10:49:43.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and points visitors to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T12:06:28.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T12:41:46.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site revision identifier in the footer was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T12:49:42.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error. This blocks access to the study record content while the standard site chrome remains visible.
    Difference
    17%
    Check dated 2026-09-19T18:31:15.000Z thumbnail image

Stay in the know with updates to KN035 Anti-PD-L1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KN035 Anti-PD-L1 Clinical Trial page.